Drug trials

FILE - This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. The German pharmaceutical company BioNTech and its U.S. partner Pfizer say they have submitted an application for conditional approval of their coronavirus vaccine with the European Medicines Agency. (Courtesy of University of Maryland School of Medicine via AP, File)
December 01, 2020 - 12:47 pm
BERLIN (AP) — The European Union drug agency said Tuesday it may need four more weeks to approve its first coronavirus vaccine, even as authorities in the United States and Britain continue to aim for a green light before Christmas. The European Medicines Agency plans to convene a meeting by Dec...
Read More
FILE - In this July 27, 2020, file photo, nurse Kathe Olmstead prepares a shot that is part of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y. Moderna Inc. says it will ask U.S. and European regulators to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection. (AP Photo/Hans Pennink, File)
KNSS News
November 30, 2020 - 8:00 am
Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection — ramping up the race to begin limited vaccinations as the coronavirus rampage worsens. Multiple vaccine candidates must...
Read More
FILE - In this file photo dated Wednesday, Sept. 2, 2020, University of Miami Miller School of Medicine lab technician processes blood samples from volunteers taking part in testing the NIH funded Moderna COVID-19 vaccine in Miami, USA. Britain said Sunday Nov. 29, 2020, it has secured 2 million more doses of a promising coronavirus vaccine developed by US firm Moderna, as the country aims to launch an inoculation program within days. (AP Photo/Taimy Alvarez, FILE)
November 29, 2020 - 12:25 pm
LONDON (AP) — Britain said Sunday it has secured 2 million more doses of a promising coronavirus vaccine as it gears up to launch within days the country's most ambitious inoculation program in decades. The U.K. has had Europe’s deadliest coronavirus outbreak, with more than 58,000 confirmed virus-...
Read More
James Teague, president of AstraZeneca's in Thailand attends a signing ceremony at Government House in Bangkok, Thailand Friday, Nov. 27, 2020. Thailand on Friday signed a deal to procure 26 million doses of the trial coronavirus vaccine developed by pharmaceutical firm AstraZeneca in collaboration with Oxford University. (Chalinee Thirasupa/Pool Photo via AP)
November 27, 2020 - 5:32 am
BANGKOK (AP) — Thailand on Friday signed a deal to procure 26 million doses of the trial coronavirus vaccine developed by pharmaceutical firm AstraZeneca in collaboration with Oxford University. It is expected to be delivered in mid-2021. The doses would cover 13 million people in a population of...
Read More
This undated photo issued by the University of Oxford shows of vial of coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. Pharmaceutical company AstraZeneca said Monday Nov. 23, 2020, that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals. (University of Oxford/John Cairns via AP)
November 26, 2020 - 6:23 pm
LONDON (AP) — The British government said Friday it has formally asked the country’s medicines regulator to assess whether a coronavirus vaccine developed by AstraZeneca and Oxford University should be authorized for use. The step comes amid questions about preliminary results from trials of the...
Read More
FILE - In this undated file photo issued by the University of Oxford on Monday, Nov. 23, 2020, a researcher in a laboratory at the Jenner Institute in Oxford, England, works on the coronavirus vaccine developed by AstraZeneca and Oxford University. With major COVID-19 vaccines showing high levels of protection, British officials are cautiously — and they stress cautiously — optimistic that life may start returning to normal by early April. Even before regulators have approved a single vaccine, the U.K. and countries across Europe are moving quickly to organize the distribution and delivery systems needed to inoculate millions of citizens. (University of Oxford/John Cairns via AP, File)
November 25, 2020 - 4:57 pm
LONDON (AP) — AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising questions about preliminary results of their experimental COVID-19 vaccine. A statement describing the error came days after the company and the university described the shots as “highly...
Read More
In this undated photo issued by the University of Oxford, a volunteer is administered the coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. Pharmaceutical company AstraZeneca said Monday Nov. 23, 2020, that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals. (University of Oxford/John Cairns via AP)
November 23, 2020 - 2:09 pm
Here's what's happening on Monday with the coronavirus pandemic in the U.S: THREE THINGS TO KNOW TODAY —Pharmaceutical company AstraZeneca said that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine...
Read More
This undated photo issued by the University of Oxford shows of vial of coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. Pharmaceutical company AstraZeneca said Monday Nov. 23, 2020, that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals. (University of Oxford/John Cairns via AP)
KNSS News
November 23, 2020 - 9:59 am
LONDON (AP) — Pharmaceutical company AstraZeneca said Monday that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals. The results are...
Read More
FILE - In this Thursday, April 23, 2020 file screen grab taken from video issued by Britain's Oxford University, showing a person being injected as part of the first human trials in the UK to test a potential coronavirus vaccine, untaken by Oxford University in England. A key researcher at the University of Oxford says scientists expect to report results from the late-stage trials of their COVID-19 vaccine by Christmas. Dr. Andrew Pollard, an expert in pediatric infection and immunity at Oxford, said Thursday, Nov. 19, 2020 that research was slowed by low infection rates over the summer but the Phase III trials are now accumulating the data needed to report results. (Oxford University Pool via AP, File)
November 19, 2020 - 6:20 am
LONDON (AP) — University of Oxford scientists expect to report results from the late-stage trials of their COVID-19 vaccine by Christmas, a key researcher said Thursday as he discussed the team’s latest findings. Dr. Andrew Pollard, an expert in pediatric infection and immunity at Oxford, said...
Read More
November 11, 2020 - 2:18 pm
MOSCOW (AP) — Developers of Sputnik V, Russia's experimental COVID-19 vaccine, announced Wednesday that early, interim data from a large trial suggests the shot appears to be 92% effective. The statement, which did not include detailed information about the trial, comes just two days after a...
Read More

Pages